INTRODUCTION

In December 2019, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) was responsible for the first cases of pneumonia of unknown etiology in the city of Wuhan, China¹. It is an RNA virus of family Coronaviridae, widely distributed among humans and other animals². The exponential growth of cases in China, reaching hundreds of countries, led the World Health Organization (WHO) to declare the disease called Coronavirus Disease 2019 (COVID-19) as a pandemic.

The disease can occur as flu-like syndrome (FLS), through fever, simultaneously with the onset of dry cough, tiredness, nasal congestion or sore throat³. However, the clinical manifestation can present as Severe Acute Respiratory Syndrome (SARS) and pneumonia, ranging from low to high criticality in patients¹. Severity is related to age and the presence of comorbidities, such as diabetes, obesity and cardiovascular diseases, with mortality of 14.8% in older adults over 80 years and with an association of fatal outcome for the presence of comorbidities for all ages.^3,4

The number of patients admitted for hospital care without progression to criticality is higher when compared to those who need beds in the Intensive Care Unit (ICU).. However, when assessing patients who evolve to the ICU, between 33% and 75% of critically ill patients require artificial respiratory support by invasive mechanical ventilation (IMV), with mortality of 10.2% for all those affected by COVID-19 and 14.6% for mechanically ventilated patients.^5,6 Mortality occurs in 61.5% of critically affected patients, in 28 days of ICU admission¹.

Thus, health professionals should be prepared for the assistance of those who evolve to ventilatory failure, with the imminent need for orotracheal intubation (OTI). However, during the assistance for definitive airway management, the team is exposed to aerosols resulting from the procedures, with risk of contamination associated with the different routes of transmission, contact with patients for a longer period of time, intense working hours and greater complexity of care tasks⁷.

The National Health Commission of China reported that 3,300 health professionals were infected during care until March 2020, with 22 deaths⁸. For the care of these patients, it is imperative to use all personal protective equipment for standard precaution, droplets and aerosols, especially for aerosol-generating procedures (AGP)⁹.

Health professionals who participate in critical AGP, such as OTI, cardiopulmonary resuscitation and airway aspiration, must be equipped with personal protective equipment (PPE), such as gloves, caps, face shield or goggles, N95 mask and waterproof apron.¹⁰ Furthermore, it is advised to perform these procedures in isolation rooms of respiratory infection with negative pressure and the use of special filters of the high-efficiency particulate air (HEPA) type in mechanical ventilators.¹⁰

New guidelines for the use of PPE constantly emerge, as well as aerosol prevention measures are updated to the knowledge of professionals and health establishments. Considering the cases of critically ill patients who require OTI and permanence in IMV, associated with the risk of exposure during PGE by the care team and the need to constantly update the guidelines for infection control, we see the need to compile the main guidelines to facilitate the reading, access and understanding of these professionals who are on the front line. Thus, this research aims to know in scientific literature what are the main prevention measures for health professionals to aerosols generated during OTI of patients suspected or confirmed for COVID-19.

METHODS

This is an integrative review, in which the six methodological steps necessary for its development were followed, namely: 1) guiding question elaboration; 2) search or sampling in literature; 3) critical analysis of included studies; 4) data collection; 5) discussion of results; and 6) integrative review presentation.¹¹ Through the strategy PICo, the research question to be investigated was elaborated: what are the aerosol exposure prevention measures during OTI by health professionals in patients suspected or confirmed for COVID-19? Population would be health professionals, Intervention, measures to prevent contamination of health professionals by the virus, and Context, exposure to aerosols during OTI.

The inclusion criteria were articles from primary studies published in Portuguese, English or Spanish, available as full texts for reading in full. This integrative review excluded studies that did not answer the research question or did not contemplate the objective, in addition to articles in the format of letters, consensus and guidelines, in addition to review articles (narrative, integrative and scoping review).

The selection of articles took place through the Virtual Health Library (VHL), in the Latin American and Caribbean Literature in Health Sciences (LILACS), Medical Literature Analysis and Retrieval System Online (MEDLINE) and Database in Nursing (BDENF) databases. Likewise, the search was carried out in the Scientific Electronic Library Online (SciELO), and, for the selection of randomized clinical studies, a search was carried out in Cochrane Wiley. To expand the selection of international studies not included in the VHL, the search was carried out through the National Library of Medicine (PubMed). During the selection in virtual libraries, the international indexed Medical Subject Headings (MeSH) descriptors were used: “COVID-19”, “aerosols”, “intubation”, “protect”. With the help of the Boolean operator AND, sets of descriptors were applied to the following databases: BDENF, LILACS, MEDLINE and Cochrane Wiley, “(COVID-19) AND (aerosols) AND (intubation)”; SciELO, “(COVID-19) AND (aerosols)”; and PubMed, “(((COVID-19) AND (aerosols)) AND (intubation)) AND (protect)”.

After the identification of primary articles, the selection process was carried out from the exclusion of duplicates, subsequent reading of titles and abstracts to exclude those that did not contemplate the research topic. The steps of identification, selection and inclusion of articles were carried out between May and June 2021 and followed the PRISMA method (Figure 1).¹²

The 22 selected primary studies were assessed for methodological scientific rigor, classified according to the level of evidence (LoE).¹³ Articles with LE I were considered to be systematic reviews or meta-analyses; LoE II, randomized controlled trials; LoE III, controlled studies without randomization; LoE IV, case-control or cohort studies; LoE V, systematic reviews of qualitative or descriptive studies; LoE VI, qualitative or descriptive studies; and LoE VII, opinions or consensus.¹³ Subsequently, the information contained in the studies was summarized, according to author, year and place of publication, objective, design and LoE, and measures to prevent aerosols from COVID-19 during OTI.

RESULTS AND DISCUSSION

A total of 22 primary studies were selected to make up this integrative review. Almost all studies were found in PubMed (20; 92%), followed by MEDLINE (1; 4%) selected through VHL and Cochrane Wiley (1; 4%). The United States published 12 (55%) articles, Canada, four (19%), Australia, two (10%), Israel, one (4%), Turkey, one (4%), England, one (4%), and Malaysia, one (4%). No studies published in Brazil or other countries in Latin and South America were identified.

Regarding the methodology, no meta-analysis studies were identified, considered the best scientific evidence among scientific studies. Randomized clinical trial-type studies made up most of the sample, with 11 (50%) whose LoE is II; non-randomized or quasi-experimental studies comprised eight (36%) of LoE III; cohort studies comprised one (5%) of LoE IV; while descriptive studies, of the case study type, totaled two (9%), of LoE VI.

Article synthesis was carried out regarding author, year and country, objective, design and level of evidence, and the main protection measures highlighted in the scientific articles, as shown in Chart 1.

Of the studies analyzed, it was found that 18 (82%) highlighted the use of barrier methods during the orotracheal intubation procedure, such as transparent plastic and acrylic box. It was observed in 3 (14%) the need for previously trained multidisciplinary intubation teams, as well as structured checklists to perform the definitive airway management procedure. According to the authors, trained intubation teams and protocols would make it possible to reduce the risks of exposure of professionals, as well as minimize unfavorable outcomes for patients infected by COVID-19. Still, 1 (5%) reported the use of an adapted orthopedic covering, which would cover the head of the intubator as a new PPE, but the disadvantage refers to mobility and difficulty in ventilation for professionals.

The need for OTI occurs in up to 75% of critically ill patients affected by COVID-19 who require direct ICU care.^5,6 However, the performance of this procedure by health professionals puts them at risk of exposure to the virus. Intubation, along with orotracheal extubation procedures, non-invasive manual ventilation, tracheostomy, oxygen support by high-flow cannula, bronchoscopy and suction of secretions by suction, are among the critical assistance supports that generate aerosols.³⁶

In an example of OTI, doctors and nurses are the professionals who are most contaminated, as they handle the upper and lower airways with very close contact, as a result of the high risk of exposure.³⁷ During the collapse in public health seen in Italy in early 2020, where the country reached the highest number of contaminations and deaths by COVID-19, about 9% of those infected were health professionals.³⁷ Thus, it is crucial to know measures that prevent exposure to the virus and the contagion of those who work in critical sectors such as emergency and ICU.

Among the articles assessed, the mandatory use of PPE is unanimous to those involved in intubation. Considering the public health emergency and the high risks of contamination of professionals during aerosol-generating procedures, it is recommended to use a N95 mask, aprons, face shield and gloves, because these devices protect professionals from direct exposure to SARS-CoV-2 viruses.^9,10 We emphasize the need for correct donning and doffing of PPE used during service, as well as the correct disposal after the OTI procedure. Carrying out the correct processes for both times of use and disuse of PPE avoids both inadvertent exposure and the risk of contamination with aerosols accumulated on professionals’ mask, gloves, face shields or apron.³⁸

When dealing with preventive measures during OTI, studies mostly bring the use of protective barriers in association with the use of PPE: devices in acrylic box format, protective plastic and cover that cover the patients’ headboard.^{14-28,32,33,35} The hypothesis raised is that only the use of PPE does not adequately protect, requiring the association of protective barriers to ensure safety.³⁶ Intubation boxes are acrylic boxes containing two holes, where the intubator allocates the arms for access to the airway, and an opening in its lower portion to attach the patients’ head.¹⁹ The application of barriers such as an acrylic box makes it possible to concentrate the aerosols inside and prevent dispersion to the environment during the procedure.^15,22,28 However, there was an increase in intubation time compared to non-use, difficulty in mobilizing the intubator and access to the airway, as well as the risk of error in the first attempt to intubate.^{15,16,18,19,21,25}

In emergencies, the delay and difficulty of access to intubate inadvertently expose patients to hypoxemia and worsening of their clinical condition.^16,23When trying to handle the airway, there was a violation of the apron and glove due to the holes in the acrylic box, exposing to risk of contamination.^19,23 The two openings designed to accommodate the intubator’s arms allow for the redirection of aerosols to the environment, with evidence of accommodation on professionals’ arms, chest and head.^14,20,26,33

Some articles highlighted the need to associate airflows with negative suction systems inside the acrylic box, coupled in HEPA filters, showing less contamination of the intubator, as well as the almost minimal dispersion to the environment.^29,32,35The post-procedure risk was also evidenced: at the end of intubation, the removal of the acrylic box allows the dispersion of aerosols concentrated inside it directly to the bedside, procedure materials, as well as the team involved.^26,28,30 If the association of barrier protectors with OTI is chosen, teams must be trained in the decontamination of boxes and plastic barriers, with additional risk of exposure during removal after completion of the procedure.^20,33

The use of protective acrylic boxes should be based on team familiarization and training of those involved in handling, in order to reduce exposure to aerosols.^20,24 The use of a video laryngoscope facilitates the visualization of the airway and avoids the increase in intubation time, providing greater safety for both professionals and patients.²⁴ Thus, teams should analyze care routines on the benefit and risk of adding barrier protectors to intubation, and the possibility of increasing the videolaryngoscope in daily life. The training of professionals to perform OTI in emergency and ICU, as well as the use of checklists that guide the methodology of the procedure, show safety for both teams and patients.^29,31,34

In a study developed in the United States, after the creation of a protocol containing guidelines on intubation (number of professionals present in the room to reduce exposure, use of tube clamps and HEPA filter, training in airway management and rapid OTI sequence), it was observed that, after 253 intubations, only 1 professional was contaminated and there was success in the first attempts, demonstrating that the application of protocols and the constant training of teams enable safety.²⁹

On the contrary, in another study, despite the complete use of PPE and training for intubation skills, of the 63 professionals, 11 were infected. First-attempt OTI success occurred in 80% of procedures.³¹ The creation of intubation teams, similar to the rapid response teams, can benefit from the guarantee of safety in performing high-risk care for teams.³⁴ Only one study addressed the use of tube clamps when passing the airway and the application of a HEPA filter to the expiratory circuit of the mechanical ventilator, as they were part of the OTI protocol.²⁹

During the assessment of articles obtained in research, it was observed that the vast majority of published studies were guidelines and experts’ recommendation letters. Recommendations regarding the association of certain OTI devices and methods in suspected or confirmed COVID-19 patients come from experts in the field to guide professionals during intubation.^{10,36,37,39,40} Among the guidelines, the following stand out: performing OTI preferably in negative pressure rooms; minimum permanence of professionals (in a negative pressure room, the permanence of a doctor, a nurse and an assistant physician in a critical room, and in an auxiliary circulating anteroom with a cardiopulmonary resuscitation cart, drugs and complete airway material); HEPA filters in the mechanical ventilator’s expiratory circuit; avoid bag-valve-mask inflation, clamps to clamp the OTT when disconnecting the ventilation system.^{10,36,37,39,40}

Although the guidelines are sources of experts in the area, there is a lack of original primary studies highlighting the efficiency of these recommendations in protecting professionals from exposure to COVID-19 aerosols. As this is a very recent topic, considering the emergence of guidelines for professionals regarding the care of critically ill patients who need a definitive airway, it is believed that there was not enough time to assess all these guidelines in methodology studies with a high level of evidence.

The limitation of this study is the research method, because it is an integrative review, and not systematic literature. Due to the very recent emergence of COVID-19, robust studies on the safety of devices such as clamps, HEPA filters, the separation of procedure rooms to avoid contamination of professionals, as well as oxygen therapy devices for the pre-oxygenation stage prior to OTI have not been identified.

Thus, with the acquisition of experience in the care of infected patients who need OTI, there is a need for original research on aerosol prevention measures for professionals involved in the procedure. The exclusion of 3 articles in other languages and 18 articles not available in full are limitations regarding the research method, inclusion and exclusion criteria.

Knowledge about methods of preventing dispersed aerosols during definitive airway management is crucial for the protection of professionals.³⁶In this way, constant updates from studies with a high level of evidence allow teams to be confident in the implementation of these measures in the daily care of patients suspected or confirmed for COVID-19.

REFERENCES

1. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8(5):475-481. https://doi.org/10.1016/s2213-2600(20)30079-5

2. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497-506. https://doi.org/10.1016/s0140-6736(20)30183-5

3. Fisher D, Heymann D. Q&A: The novel coronavirus outbreak causing COVID-19. BMC Med 2020;18(1):57. https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-020-01533-w

4. Bae S, Kim SR, Kim MN, et al. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis. Heart. 2021;107:373–380. https://doi.org/10.1136/heartjnl-2020-317901

5. Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in Critically Ill Patients in the Seattle Region — Case Series. N Engl J Med 2020;382(21):2012-2022. https://doi.org/10.1056/nejmoa2004500

6. Goyal P, Choi JJ, Pinheiro LC, et al. Clinical Characteristics of Covid-19 in New York City. N Engl J Med 2020;382(24):2372-2374. https://doi.org/10.1056/nejmc2010419

7. Liu Y, Jinxiu L, Feng Y. Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China. Crit Care 2020;24(1):56. https://doi.org/10.1186/s13054-020-2786-x

8. The Lancet. COVID-19: protecting health-care workers. The Lancet 2020; 395(10228):922. https://doi.org/10.1016/S0140-6736(20)30644-9

9. Chang D, Xu H, Rebaza A, et al. Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med 2020;8(3):e13. https://doi.org/10.1016/s0140-6736(20)30644-9

10. Centers for Disease Control and Prevention. Interim infection prevention and control recommendations for patients with suspected or confirmed Coronavirus Disease 2019 (COVID-19) in healthcare settings. CDC, 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html

11. Souza MT, Silva MD, Carvalho R. Integrative review: what is it? How to do it? Revista Einstein 2009;8(1):102-06. https://doi.org/10.1590/S1679-45082010RW1134

12. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. https://doi.org/10.1136/bmj.n71

13. Stillwell SB, Fineout-Overholt E, Melnyk BM, et al. Searching for the Evidence: Strategies to help you conduct a successful search. American Journal of Nursing (AJN) 2010;110(1):51-23. https://doi.org/10.1097/01.naj.0000372071.24134.7e

14. Rose P, Veall J, Chima N, et al. A comparison of droplet and contact contamination using 3 simulated barrier techniques for COVID-19 intubation: a quality assurance study. CMAJ Open 2020;8(3):E554-E559. https://doi.org/10.9778/cmajo.20200090

15. Azhar M, Bustam A, Poh K, et al. COVID-19 aerosol box as protection from droplet and aerosol contaminations in healthcare workers performing airway intubation: a randomised cross-over simulation study. Emergency Medicine Journal 2021;38.111-117. https://doi.org/10.1136/emermed-2020-210514

16. Turner JS, Falvo LE, Ahmed RA, et al. Effect of an Aerosol Box on Intubation in Simulated Emergency Department Airways: A Randomized Crossover Study. West J Emerg Med 2020;21(6):78-82. https://doi.org/10.5811/westjem.2020.8.48901

17. Derrick J, Thatcher J, Wong JCP. Efficacy of an enclosure for reducing aerosol exposure during patient intubation. Med J Aust 2020;213(8):372-373. https://doi.org/10.5694/mja2.50761

18. Feldman O, Samuel N, Kvatinsky N, et al. Endotracheal intubation of COVID-19 patients by paramedics using a box barrier: A randomized crossover manikin study. PLoS One 2021;16(3):e0248383. https://doi.org/10.1371/journal.pone.0248383

19. Fong S, Li E, Violato E, et al. Impact of aerosol box on intubation during COVID-19: a simulation study of normal and difficult airways. Can J Anaesth 2021;68(4):496-504. https://doi.org/10.1007/s12630-020-01825-y

20. Burnett GW, Zhou G, Fried EA, et al. Intraoperative aerosol box use: does an educational visual aid reduce contamination? Korean J Anesthesiol 2021;74(2):158-164. https://doi.org/10.4097/kja.20511

21. Ozbek AE, Sanci E, Halhalli HC. Effect of using barrier devices on intubation times and performance - a randomized, prospective, crossover manikin study. Notfall Rettungsmed (2021). https://link.springer.com/article/10.1007%2Fs10049-021-00860-6#article-info

22. Querney J, Cubillos J, Ding Y, et al. Patient barrier acceptance during airway management among anesthesiologists: a simulation pilot study. Korean J Anesthesiol 2021;74(3):254-261. https://doi.org/10.4097/kja.20464

23. Begley JL, Lavery KE, Nickson CP, et al. The aerosol box for intubation in coronavirus disease 2019 patients: an in-situ simulation crossover study. Anaesthesia 2020;75(8):1014-1021. https://doi.org/10.1111/anae.15115

24. Madabhushi P, Kinthala S, Ankam A, et al. Time to adapt in the pandemic era: a prospective randomized non -inferiority study comparing time to intubate with and without the barrier box. BMC Anesthesiol 2020;20(1):232. https://doi.org/10.1186/s12871-020-01149-w

25. Ben-Yakov M, Price C, Dharamsi A, et al. Intubator Performance and Contamination with the Use of Barrier Enclosure Devices: Results from a Simulated COVID-19 Resuscitation. Ann Work Expo Health 2021:wxaa144. https://doi.org/10.1093/annweh/wxaa144

26. Fidler RL, Niedek CR, Teng JJ, et al. Aerosol Retention Characteristics of Barrier Devices. Anesthesiology 2021;134(1):61-71. https://doi.org/10.1097/aln.0000000000003597

27. Bryant J, Tobias JD. Enclosure with augmented airflow to decrease risk of exposure to aerosolized pathogens including coronavirus during endotracheal intubation. Can the reduction in aerosolized particles be quantified? Paediatr Anaesth 2020;30(8):900-904. https://doi.org/10.1111/pan.13934

28. Gore RK, Saldana C, Wright DW, et al. Intubation Containment System for Improved Protection From Aerosolized Particles During Airway Management. IEEE J Transl Eng Health Med 2020;8:1600103. https://doi.org/10.1109/jtehm.2020.2993531

29. Patel GP, Collins JS, Sullivan CL, et al. Management of Coronavirus Disease 2019 Intubation Teams. A A Pract 2020;14(8):e01263. https://doi.org/10.1213/xaa.0000000000001263

30. Wills TT, Zuelzer WA, Tran BW. Utilization of an Orthopedic Hood as Personal Protective Equipment for Intubation of Coronavirus Patients: a Brief Technical Report. Geriatr Orthop Surg Rehabil 2020;11:2151459320930554. https://doi.org/10.1177/2151459320930554

31. Ahmad I, Jeyarajah J, Nair G, et al. A prospective, observational, cohort study of airway management of patients with COVID-19 by specialist tracheal intubation teams. Can J Anaesth 2021;68(2):196-203. https://doi.org/10.1007/s12630-020-01804-3

32. Brant-Zawadzki GM, Ockerse P, Brunson JR, et al. An Aerosol Containment and Filtration Tent for Intubation During the COVID-19 Pandemic. Surg Innov 2021;28(2):226-230. https://doi.org/10.1177/1553350621999976

33. Fried EA, Zhou G, Shah R, et al. Barrier Devices, Intubation, and Aerosol Mitigation Strategies: Personal Protective Equipment in the Time of Coronavirus Disease 2019. Anesth Analg 2021;132(1):38-45. https://doi.org/10.1213/ane.0000000000005249

34. Tronnier A, Mulcahy CF, Pierce A, et al. COVID-19 Intubation Safety: A Multidisciplinary, Rapid-Cycle Model of Improvement. Am J Med Qual 2020;35(6):450-457. https://doi.org/10.1177/1062860620949141

35. Turer DM, Good CH, Schilling BK, et al. Improved Testing and Design of Intubation Boxes During the COVID-19 Pandemic. Ann Emerg Med 2021;77(1):1-10. https://doi.org/10.1016/j.annemergmed.2020.08.033

36. Saito T, Asai T. Aerosol containment device for airway management of patients with COVID-19: a narrative review. J Anesth 2021;35(3):384-389. https://doi.org/10.1007/s00540-020-02879-4

37. Paterlini M. On the front lines of coronavirus: the Italian response to covid-19. BMJ 2020;368:m1065. https://doi.org/10.1136/bmj.m1065

38. Neto CFMA, Oliveira ACS, Brito AP, et al. Training on the use and disposal of protective equipment individual in suspected or confirmed cases of the new coronavirus in a basic health unit in Uruará-PA. Brazilian Journal of Development 2021;7(1):3286-3296. ttps://doi.org/10.34117/bjdv7n1-222

39. Thiruvenkatarajan V, Wong DT, Kothandan H, et al. Airway Management in the Operating Room and Interventional Suites in Known or Suspected COVID-19 Adult Patients: A Practical Review. Anesth Analg 2020;131(3):677-689. https://doi.org/10.1213/ane.0000000000005043

40. Associação Brasileira de Medicina de Emergência, Sociedade Brasileira de Cardiologia, Associação de Medicina Intensiva Brasileira. Recomendações para Intubação Orotraqueal em pacientes portadores de COVID-19. ABRAMEDE. 2020, 1-18.http://abramede.com.br/wp-content/uploads/2020/06/RECOMENDACOES-IOT-V05-120520.pdf